In addition to being a potent virucidal, HBOT is a good treatment option for Covid patients, and here’s why:
Covid-19 creates inflammation in the lung itself, preventing O2 from reaching the bloodstream and resulting in organ hypoxia and, in some cases, organ failure. Mechanical ventilation forces air/oxygen into the lungs, but it is not particularly effective at forcing O2 into the bloodstream. Mechanical ventilation is marginal at resolving the hypoxia it seeks to treat and forced ventilation causes further stress to the lungs. The mortality rate among ventilated patients is 50%.
The increased pressure that a hyperbaric oxygen chamber produces oxygenates the fluid of the body directly, without relying on the blood supply. This relieves organ hypoxia much more quickly without stressing lung tissue. And, because high levels of O2 are a potent anti-inflammatory, HBOT also addresses the inflammation in the lungs themselves, which is what is preventing oxygen from reaching the bloodstream in the first place. Dr. Paul Harch notes that in addition to lowering the mortality rate, HBOT averts mechanical ventilation of patients and shortens hospital stays. https://youtu.be/V96E6O7I9Es
The other issues that are of concern with Covid-19 are the ensuing cytokine storm, and issues with coagulation in the blood. HBOT is a great match for these as well. Doctors in Wuhan, China reported “promising results” after treating COVID-19 patients with HBOT. Two were in critical condition and five were severe. Patients experienced rapid relief of hypoxic symptoms, rapid correction of hypoxemia, improved lung pathology and a general reversal of associated conditions, including gastrointestinal symptoms. https://drive.google.com/file/d/1pjtuT44daBvc8LubVYcR064PLpgIjiFY/view
Opelousas General Hospital in Louisiana, which has a hyperbaric center, has been deploying “off-label compassionate use” of HBOT as an alternative for patients that would otherwise have required ventilation. Dr. Kelly Thibodeaux Thibodeaux presented his case findings in a recent webinar held by the Association for the Advancement of Wound Care (AAWC). In this video, Thibodeaux reviews the details for the first five cases. These patients received between 1-9 treatments, and all saw rapid improvements in their respiratory rates and dramatic decreases in CRP (an inflammatory marker) and D-dimer (a measure of blood coagulation). These finding also demonstrated that HBOT was effective in:
- Reversing hypoxia
- Reducing inflammation in the lungs
- Increasing viricidal reactive oxygen species
- Upregulating HIF-increasing host defense peptides
- Reducing proinflammatory cytokines such as IL-6, IL-1B, IL 18, TNF alpha and NF kappa B
Thibodeaux, who is board certified in general surgery and wound care, collaborated with Dr. Amer Raza, a doctor of pulmonology and critical care, to develop an inclusive treatment plan using HBOT once a day for 90 minutes.2
Clinicaltrials.gov lists six trials underway or getting started, with two more in Iowa and West Virginia under compassionate use. In sum: HBOT to fight COVID-19 is already showing terrific results at reversing the effects of the pandemic and saving patients from having to go onto ventilators. Hyperbaric Oxygen Therapy (HBOT) answers the call. It is the fastest, safest and least expensive way to arrest and reverse the effects of the coronavirus.
The use of HBOT for the treatment of COVID-19 is supported by various international clinical trials and recognized by the World Health Organization as a non-drug treatment for COVID-19. Nine clinical trials are currently underway across Europe, Middle East and North America at the time this was published.